AmCad BioMed Corporation (TPEX:4188)

AmCad BioMed Revenue

AmCad BioMed had revenue of 6.72M TWD in the quarter ending June 30, 2026, a decrease of -17.66%. This brings the company's revenue in the last twelve months to 28.60M, down -34.39% year-over-year. In the year 2025, AmCad BioMed had annual revenue of 30.44M, down -42.69%.

• Revenue (ttm): 28.60M
• Revenue Growth: -34.39%
• P/S Ratio: 32.33
• Revenue / Employee: 841.26K
• Employees: 34
• Market Cap: 924.66M

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	30.44M	-22.67M	-42.69%
Dec 31, 2024	53.11M	-12.15M	-18.62%
Dec 31, 2023	65.26M	3.63M	5.88%
Dec 31, 2022	61.63M	-24.16M	-28.16%
Dec 31, 2021	85.79M	21.85M	34.17%

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 24, 2026

Data Sources Report a data error